Mara Boschetti Selected Research

Mara Boschetti Research Topics

Disease

9	Neoplasms (Cancer) 03/2024 - 07/2005
5	Acromegaly 12/2020 - 10/2013
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 07/2005
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2019 - 04/2007
2	Type 2 Diabetes Mellitus (MODY) 03/2024 - 03/2020
2	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 06/2006
2	Disease Progression 08/2023 - 10/2021
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2023 - 08/2013
2	Pituitary ACTH Hypersecretion 02/2019 - 06/2006
2	Adenoma (Adenomas) 02/2019 - 04/2007
2	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2013 - 02/2007
1	Hyponatremia 01/2023
1	Agenesis of Corpus Callosum 01/2023
1	Hypocalcemia 10/2021
1	Hypoparathyroidism 10/2021
1	Chronic Disease (Chronic Diseases) 12/2020
1	Pituitary Diseases (Disease, Anterior Pituitary) 12/2020
1	Growth Hormone-Secreting Pituitary Adenoma 02/2019
1	ACTH-Secreting Pituitary Adenoma 02/2019
1	Metabolic Bone Diseases (Osteopenia) 08/2016
1	Thalassemia 08/2016
1	Osteoporosis 08/2016
1	Carcinogenesis 10/2013
1	Breast Neoplasms (Breast Cancer) 10/2013
1	Hypothyroidism 08/2013
1	Overweight 08/2013
1	Cushing Syndrome 01/2010
1	Prolactinoma (Prolactinomas) 04/2007
1	Heart Failure 02/2007
1	Insulin Resistance 02/2007
1	Obesity 02/2007
1	Optic Nerve Diseases (Optic Neuropathy) 06/2006
1	Hemianopsia (Bitemporal Hemianopsia) 06/2006
1	Glioma (Gliomas) 06/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2005
1	Hodgkin Disease (Hodgkin's Disease) 07/2005
1	Thymoma (Thymic Carcinoma) 07/2005
1	Lymphoma (Lymphomas) 07/2005
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 07/2005

Drug/Important Bio-Agent (IBA)

5	Growth Hormone (Somatotropin)IBA 12/2020 - 08/2013
3	Insulin-Like PeptidesIBA 12/2020 - 08/2016
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2020 - 07/2005
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2019 - 07/2005
3	LigandsIBA 02/2019 - 07/2005
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2019 - 07/2005
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2010 - 04/2007
2	Vitamin D FDA LinkGeneric 08/2023 - 10/2013
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2023 - 01/2010
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 04/2007
2	Insulin-Like Growth Factor I (IGF-1)IBA 08/2016 - 02/2007
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2013 - 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 03/2024
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2023
1	hydroxide ionIBA 08/2023
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 05/2023
1	SodiumIBA 01/2023
1	Tolvaptan FDA Link 01/2023
1	MagnesiumIBA 10/2021
1	CalciumIBA 10/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	IncretinsIBA 03/2020
1	pasireotideIBA 02/2019
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 08/2016
1	Somatomedins (Somatomedin)IBA 08/2016
1	ParaffinIBA 01/2016
1	calcium phosphateIBA 10/2013
1	LipidsIBA 08/2013
1	Glucose (Dextrose)FDA LinkGeneric 08/2013
1	Dopamine (Intropin)FDA LinkGeneric 01/2010
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2007
1	Hormones (Hormone)IBA 04/2007
1	Testosterone (Sustanon)FDA Link 02/2007
1	Prednisone (Sone)FDA LinkGeneric 06/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2006
1	Analgesics (Analgesic Drugs)IBA 06/2006
1	Pentetic Acid (DTPA)FDA LinkGeneric 07/2005
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 07/2005

Therapy/Procedure

8	Therapeutics 12/2020 - 07/2005
3	Radiotherapy 01/2020 - 06/2006
1	Thyroidectomy 10/2021
1	Contraindications 10/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Hyperbaric Oxygenation 06/2006